sb 202190 has been researched along with Carcinoma, Anaplastic in 2 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
Excerpt | Relevance | Reference |
---|---|---|
"Human colon cancer cells (Caco-2) were stimulated with increasing concentrations of sodium chloride (NaCl) or LPS." | 1.31 | Epithelial cyclooxygenase-2 expression: a model for pathogenesis of colon cancer. ( Arbabi, S; Garcia, I; Jelacic, S; Maier, RV; Rosengart, MR, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chao, JI | 1 |
Kuo, PC | 1 |
Hsu, TS | 1 |
Arbabi, S | 1 |
Rosengart, MR | 1 |
Garcia, I | 1 |
Jelacic, S | 1 |
Maier, RV | 1 |
2 other studies available for sb 202190 and Carcinoma, Anaplastic
Article | Year |
---|---|
Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Arsenites; Benzazepines; Blotting, Western; Carcinoma; CDC2 Protei | 2004 |
Epithelial cyclooxygenase-2 expression: a model for pathogenesis of colon cancer.
Topics: Carcinoma; Colonic Neoplasms; Cyclooxygenase 2; Dose-Response Relationship, Drug; Enzyme Inhibitors; | 2001 |